PuSH - Publikationsserver des Helmholtz Zentrums München

Morath, C.* ; Schmied, B.* ; Mehrabi, A.* ; Weitz, J.* ; Schmidt, J.* ; Werner, J.* ; Büchler, M.W.* ; Morcos, M.* ; Nawroth, P.P.* ; Schwenger, V.* ; Doehler, B.* ; Opelz, G.* ; Zeier, M.*

Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.

Clin. Transplant. 23, 33-36 (2009)
DOI Verlagsversion bestellen
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Renin-angiotensin system blockade retards the progression of diabetic and non-diabetic chronic kidney disease of the native kidneys. Though most patients suffer from a significant renal insufficiency (chronic kidney disease stage III) and a concomitant heart disease after renal transplantation, there is up to now no evidence supporting the use of inhibitors of the renin-angiotensin system in these patients. We wish to summarize the available evidence on the use of inhibitors of the renin-angiotensin system after renal transplantation. We specifically discuss potential beneficial as well as adverse effects of a renin-angiotensin system blockade. In addition, we review their influence on morphologic and biochemical markers as well as on renal function, graft and patient survival after renal transplantation.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
ISSN (print) / ISBN 0902-0063
e-ISSN 1399-0012
Zeitschrift Clinical Transplantation / Supplement
Quellenangaben Band: 23, Heft: , Seiten: 33-36 Artikelnummer: , Supplement: ,
Verlag Wiley
Begutachtungsstatus
Institut(e) Institute for Pancreatic Beta Cell Research (IPI)